7-Chlorolincomycin Therapy of Pulmonary Infections Due to Mycoplasma pneumoniae
AUTOR(ES)
Axelrod, Judith
RESUMO
Nine ill patients with serologically proved pulmonary infection due to Mycoplasma pneumoniae were treated with 7-chlorolincomycin. The symptomatic responses with 900 to 1,200-mg doses were dramatic.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444345Documentos Relacionados
- Microbiological and Pharmacological Behavior of 7-Chlorolincomycin
- Molecular Approaches to Diagnosis of Pulmonary Diseases Due to Mycoplasma pneumoniae
- Significant Role of Interleukin-8 in Pathogenesis of Pulmonary Disease Due to Mycoplasma pneumoniae Infection
- Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae
- Possible Influence of Antibiotic Therapy on Usefulness of Metabolic Inhibition Test for Diagnosis of Mycoplasma pneumoniae Infections
